Tag "OSL"
Singapore’s GIC Invests US$ 70 Million in Digital Asset Firm BC Group
BC Technology Group, a digital asset and fintech company as well as the parent company of OSL, secured an investment of US$ 70 million (HKD 543.19 million) from GIC, a Singaporean sovereign wealth fund. The company intends to develop and enhance
Read More
HK’s BC Group Partners StanChart to Launch Crypto Platform for Institutional Clients
SC Ventures, the innovation and ventures unit of Standard Chartered, announced a partnership with BC Technology Group, the parent company of Hong Kong’s licensed digital asset platform OSL. The joint venture (JV) was formed to establish a digital asset brokerage and
Read More
Hong Kong’s OSL Facilitated Meitu’s US$ 10 M Bitcoin Transaction
OSL announced that its SFC-licensed digital asset brokerage OSL Digital Securities acted as the trade execution and custody partner for Hong Kong-listed Meitu, and facilitated its latest digital asset treasury transaction, a purchase of approximately 175 units of Bitcoin with
Read More
SFC-Licensed Crypto Trading Platform OSL Goes Live
OSL Digital Securities Limited (OSL DS), a SFC-licensed digital asset platform and member of BC Technology Group, announced that it has officially gone live with the execution of the first customer trades via its licensed trading desk. OSL DS holds
Read More
OSL Receives Green Light From Hong Kong Regulator for Crypto Trading Platform
OSL, a digital asset platform and member of BC Technology Group, has received the license from Hong Kong’s Securities and Futures Commission (SFC) to operate regulated brokerage and automated trading services for digital assets following a rigorous vetting process. They
Read More
SFC Issues Approval-In-Principle to OSL for Virtual Asset Trading Platform
Hong Kong’s Securities and Futures Commission (SFC), has issued an approval-in-principle for OSL, Asia’s digital asset platform and member of BC Technology Group, to operate a virtual asset trading platform. The platform will be operated under a license for Type 1
Read More